rs141323589

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001160148.2(DDHD1):​c.453G>A​(p.Pro151Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00351 in 1,613,068 control chromosomes in the GnomAD database, including 251 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0065 ( 41 hom., cov: 32)
Exomes 𝑓: 0.0032 ( 210 hom. )

Consequence

DDHD1
NM_001160148.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.15

Publications

2 publications found
Variant links:
Genes affected
DDHD1 (HGNC:19714): (DDHD domain containing 1) This gene is a member of the intracellular phospholipase A1 gene family. The protein encoded by this gene preferentially hydrolyzes phosphatidic acid. It is a cytosolic protein with some mitochondrial localization, and is thought to be involved in the regulation of mitochondrial dynamics. Overexpression of this gene causes fragmentation of the tubular structures in mitochondria, while depletion of the gene results in mitochondrial tubule elongation. Deletion of this gene in male mice caused fertility defects, resulting from disruption in the organization of the mitochondria during spermiogenesis. In humans, mutations in this gene have been associated with hereditary spastic paraplegia (HSP), also known as Strumpell-Lorrain disease, or, familial spastic paraparesis (FSP). This inherited disorder is characterized by progressive weakness and spasticity of the legs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
DDHD1-DT (HGNC:55441): (DDHD1 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 14-53152646-C-T is Benign according to our data. Variant chr14-53152646-C-T is described in ClinVar as Benign. ClinVar VariationId is 380446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.15 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0529 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001160148.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DDHD1
NM_001160148.2
MANE Select
c.453G>Ap.Pro151Pro
synonymous
Exon 1 of 13NP_001153620.1Q8NEL9-1
DDHD1
NM_001160147.2
c.453G>Ap.Pro151Pro
synonymous
Exon 1 of 13NP_001153619.1Q8NEL9-4
DDHD1
NM_030637.3
c.453G>Ap.Pro151Pro
synonymous
Exon 1 of 12NP_085140.2Q8NEL9-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DDHD1
ENST00000673822.2
MANE Select
c.453G>Ap.Pro151Pro
synonymous
Exon 1 of 13ENSP00000500986.2Q8NEL9-1
DDHD1
ENST00000357758.3
TSL:1
c.453G>Ap.Pro151Pro
synonymous
Exon 1 of 12ENSP00000350401.3Q8NEL9-2
DDHD1
ENST00000907176.1
c.453G>Ap.Pro151Pro
synonymous
Exon 1 of 15ENSP00000577235.1

Frequencies

GnomAD3 genomes
AF:
0.00647
AC:
984
AN:
152190
Hom.:
41
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00159
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0558
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00503
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00860
GnomAD2 exomes
AF:
0.0144
AC:
3553
AN:
247212
AF XY:
0.0105
show subpopulations
Gnomad AFR exome
AF:
0.00115
Gnomad AMR exome
AF:
0.0970
Gnomad ASJ exome
AF:
0.00161
Gnomad EAS exome
AF:
0.00584
Gnomad FIN exome
AF:
0.0000466
Gnomad NFE exome
AF:
0.0000631
Gnomad OTH exome
AF:
0.0105
GnomAD4 exome
AF:
0.00320
AC:
4673
AN:
1460760
Hom.:
210
Cov.:
31
AF XY:
0.00268
AC XY:
1944
AN XY:
726726
show subpopulations
African (AFR)
AF:
0.000836
AC:
28
AN:
33474
American (AMR)
AF:
0.0938
AC:
4193
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.00130
AC:
34
AN:
26120
East Asian (EAS)
AF:
0.00386
AC:
153
AN:
39686
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86248
European-Finnish (FIN)
AF:
0.0000190
AC:
1
AN:
52596
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000459
AC:
51
AN:
1111850
Other (OTH)
AF:
0.00333
AC:
201
AN:
60320
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
255
510
765
1020
1275
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00648
AC:
987
AN:
152308
Hom.:
41
Cov.:
32
AF XY:
0.00708
AC XY:
527
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.00159
AC:
66
AN:
41578
American (AMR)
AF:
0.0560
AC:
856
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3468
East Asian (EAS)
AF:
0.00504
AC:
26
AN:
5156
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4830
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
68036
Other (OTH)
AF:
0.00851
AC:
18
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
51
102
154
205
256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00190
Hom.:
1
Bravo
AF:
0.0122
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000237

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
Hereditary spastic paraplegia (1)
-
-
1
Hereditary spastic paraplegia 28 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
4.9
DANN
Benign
0.95
PhyloP100
-1.2
PromoterAI
0.045
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141323589; hg19: chr14-53619364; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.